#RPGLIFE | 📌 RPG Life Sciences Limited posted strong Q3 FY25 results: 12% Y-o-Y revenue growth, 32% Y-o-Y PBT surge, and EBITDA margin up from 25.9% to 30.4% Y-o-Y. As part of RPG Enterprises, the company targets growth in both domestic and international markets.

Details:⚡ AI powered update byCheck-outto receive WhatsApp updates faster than twitter/X.
#RPGLIFE